J FUNCT FOODS 润色咨询

Journal of Functional Foods

出版年份:2009 年文章数:4303 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:12.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2145064, encodeId=c0e72145064ca, content=为什么PubMed和WOS搜不到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Tue Jun 27 18:35:51 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2181071, encodeId=a29021810e106, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:中药;肠道菌群<br>经验分享:正在投稿中,期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13435547176, createdName=ms3000000331499189, createdTime=Fri Jan 12 22:29:17 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2112105, encodeId=1b9121121052b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:2022-11-07 submission<br>2022-12-21 Under Review<br>2023-01-05 Required Reviews Completed, major revision<br>2023-01-28 重新提交修改稿, with edtior<br>2023-01-29 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21d92362370, createdName=Sweet123, createdTime=Mon Jan 30 12:06:58 CST 2023, time=2023-01-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187884, encodeId=fc93218e884ce, content=请问大家,第一次投稿JFF,with editor后直接decision in process是拒稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Sun Feb 18 08:03:27 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186348, encodeId=dbc72186348eb, content=审稿速度:2.0<br>偏重的研究方向:食品功能<br>经验分享:返修中,期待有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d538538122, createdName=ms6000002095545543, createdTime=Wed Feb 07 13:19:12 CST 2024, time=2024-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2150747, encodeId=3c822150e474b, content=想问一下 这个杂志 可选非OA吗?版面费太贵了<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Aug 01 10:32:16 CST 2023, time=2023-08-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=573893, encodeId=f4455e3893bf, content=请问后面接受了吗?<span class="quote">Cminor的忧郁 2019-04-29 00:00:00 发表:<br>四个月了还在under review</span>, beContent=Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5042220513, createdName=120fb885m31(暂无昵称), createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581042, encodeId=f3ba58104245, content=这个杂志的文章为什么在pubmed搜不到?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d2f1675433, createdName=Todbio, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056315, encodeId=1c49105631504, content=这个杂志的文章,为什么知网和pub med都搜不到呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/e31c71b7378048e29cf3e99f8858c0da/f8a0c38f56ec4460ac9c91ae10e0571a.jpg, createdBy=c39f5362798, createdName=ms7866968361536942, createdTime=Wed Sep 29 23:31:20 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856426, encodeId=f56a8564267a, content=已经oa了,收费1750刀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcef5414005, createdName=ms1092406316746404, createdTime=Fri Jan 03 10:27:16 CST 2020, time=2020-01-03, status=1, ipAttribution=)]
    2023-06-27 178Ob6 来自北京

    为什么PubMed和WOS搜不到呀

    5

    展开5条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2145064, encodeId=c0e72145064ca, content=为什么PubMed和WOS搜不到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Tue Jun 27 18:35:51 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2181071, encodeId=a29021810e106, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:中药;肠道菌群<br>经验分享:正在投稿中,期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13435547176, createdName=ms3000000331499189, createdTime=Fri Jan 12 22:29:17 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2112105, encodeId=1b9121121052b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:2022-11-07 submission<br>2022-12-21 Under Review<br>2023-01-05 Required Reviews Completed, major revision<br>2023-01-28 重新提交修改稿, with edtior<br>2023-01-29 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21d92362370, createdName=Sweet123, createdTime=Mon Jan 30 12:06:58 CST 2023, time=2023-01-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187884, encodeId=fc93218e884ce, content=请问大家,第一次投稿JFF,with editor后直接decision in process是拒稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Sun Feb 18 08:03:27 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186348, encodeId=dbc72186348eb, content=审稿速度:2.0<br>偏重的研究方向:食品功能<br>经验分享:返修中,期待有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d538538122, createdName=ms6000002095545543, createdTime=Wed Feb 07 13:19:12 CST 2024, time=2024-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2150747, encodeId=3c822150e474b, content=想问一下 这个杂志 可选非OA吗?版面费太贵了<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Aug 01 10:32:16 CST 2023, time=2023-08-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=573893, encodeId=f4455e3893bf, content=请问后面接受了吗?<span class="quote">Cminor的忧郁 2019-04-29 00:00:00 发表:<br>四个月了还在under review</span>, beContent=Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5042220513, createdName=120fb885m31(暂无昵称), createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581042, encodeId=f3ba58104245, content=这个杂志的文章为什么在pubmed搜不到?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d2f1675433, createdName=Todbio, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056315, encodeId=1c49105631504, content=这个杂志的文章,为什么知网和pub med都搜不到呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/e31c71b7378048e29cf3e99f8858c0da/f8a0c38f56ec4460ac9c91ae10e0571a.jpg, createdBy=c39f5362798, createdName=ms7866968361536942, createdTime=Wed Sep 29 23:31:20 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856426, encodeId=f56a8564267a, content=已经oa了,收费1750刀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcef5414005, createdName=ms1092406316746404, createdTime=Fri Jan 03 10:27:16 CST 2020, time=2020-01-03, status=1, ipAttribution=)]
    2024-01-12 ms3000000331499189 来自北京

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向:中药;肠道菌群
    经验分享:正在投稿中,期待好消息

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2145064, encodeId=c0e72145064ca, content=为什么PubMed和WOS搜不到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Tue Jun 27 18:35:51 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2181071, encodeId=a29021810e106, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:中药;肠道菌群<br>经验分享:正在投稿中,期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13435547176, createdName=ms3000000331499189, createdTime=Fri Jan 12 22:29:17 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2112105, encodeId=1b9121121052b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:2022-11-07 submission<br>2022-12-21 Under Review<br>2023-01-05 Required Reviews Completed, major revision<br>2023-01-28 重新提交修改稿, with edtior<br>2023-01-29 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21d92362370, createdName=Sweet123, createdTime=Mon Jan 30 12:06:58 CST 2023, time=2023-01-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187884, encodeId=fc93218e884ce, content=请问大家,第一次投稿JFF,with editor后直接decision in process是拒稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Sun Feb 18 08:03:27 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186348, encodeId=dbc72186348eb, content=审稿速度:2.0<br>偏重的研究方向:食品功能<br>经验分享:返修中,期待有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d538538122, createdName=ms6000002095545543, createdTime=Wed Feb 07 13:19:12 CST 2024, time=2024-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2150747, encodeId=3c822150e474b, content=想问一下 这个杂志 可选非OA吗?版面费太贵了<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Aug 01 10:32:16 CST 2023, time=2023-08-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=573893, encodeId=f4455e3893bf, content=请问后面接受了吗?<span class="quote">Cminor的忧郁 2019-04-29 00:00:00 发表:<br>四个月了还在under review</span>, beContent=Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5042220513, createdName=120fb885m31(暂无昵称), createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581042, encodeId=f3ba58104245, content=这个杂志的文章为什么在pubmed搜不到?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d2f1675433, createdName=Todbio, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056315, encodeId=1c49105631504, content=这个杂志的文章,为什么知网和pub med都搜不到呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/e31c71b7378048e29cf3e99f8858c0da/f8a0c38f56ec4460ac9c91ae10e0571a.jpg, createdBy=c39f5362798, createdName=ms7866968361536942, createdTime=Wed Sep 29 23:31:20 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856426, encodeId=f56a8564267a, content=已经oa了,收费1750刀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcef5414005, createdName=ms1092406316746404, createdTime=Fri Jan 03 10:27:16 CST 2020, time=2020-01-03, status=1, ipAttribution=)]
    2023-01-30 Sweet123 来自山东省

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享:2022-11-07 submission
    2022-12-21 Under Review
    2023-01-05 Required Reviews Completed, major revision
    2023-01-28 重新提交修改稿, with edtior
    2023-01-29 Accept

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2145064, encodeId=c0e72145064ca, content=为什么PubMed和WOS搜不到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Tue Jun 27 18:35:51 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2181071, encodeId=a29021810e106, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:中药;肠道菌群<br>经验分享:正在投稿中,期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13435547176, createdName=ms3000000331499189, createdTime=Fri Jan 12 22:29:17 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2112105, encodeId=1b9121121052b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:2022-11-07 submission<br>2022-12-21 Under Review<br>2023-01-05 Required Reviews Completed, major revision<br>2023-01-28 重新提交修改稿, with edtior<br>2023-01-29 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21d92362370, createdName=Sweet123, createdTime=Mon Jan 30 12:06:58 CST 2023, time=2023-01-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187884, encodeId=fc93218e884ce, content=请问大家,第一次投稿JFF,with editor后直接decision in process是拒稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Sun Feb 18 08:03:27 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186348, encodeId=dbc72186348eb, content=审稿速度:2.0<br>偏重的研究方向:食品功能<br>经验分享:返修中,期待有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d538538122, createdName=ms6000002095545543, createdTime=Wed Feb 07 13:19:12 CST 2024, time=2024-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2150747, encodeId=3c822150e474b, content=想问一下 这个杂志 可选非OA吗?版面费太贵了<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Aug 01 10:32:16 CST 2023, time=2023-08-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=573893, encodeId=f4455e3893bf, content=请问后面接受了吗?<span class="quote">Cminor的忧郁 2019-04-29 00:00:00 发表:<br>四个月了还在under review</span>, beContent=Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5042220513, createdName=120fb885m31(暂无昵称), createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581042, encodeId=f3ba58104245, content=这个杂志的文章为什么在pubmed搜不到?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d2f1675433, createdName=Todbio, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056315, encodeId=1c49105631504, content=这个杂志的文章,为什么知网和pub med都搜不到呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/e31c71b7378048e29cf3e99f8858c0da/f8a0c38f56ec4460ac9c91ae10e0571a.jpg, createdBy=c39f5362798, createdName=ms7866968361536942, createdTime=Wed Sep 29 23:31:20 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856426, encodeId=f56a8564267a, content=已经oa了,收费1750刀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcef5414005, createdName=ms1092406316746404, createdTime=Fri Jan 03 10:27:16 CST 2020, time=2020-01-03, status=1, ipAttribution=)]
    2024-02-18 ms8000000941838223 来自北京

    请问大家,第一次投稿JFF,with editor后直接decision in process是拒稿吗?

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2145064, encodeId=c0e72145064ca, content=为什么PubMed和WOS搜不到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Tue Jun 27 18:35:51 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2181071, encodeId=a29021810e106, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:中药;肠道菌群<br>经验分享:正在投稿中,期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13435547176, createdName=ms3000000331499189, createdTime=Fri Jan 12 22:29:17 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2112105, encodeId=1b9121121052b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:2022-11-07 submission<br>2022-12-21 Under Review<br>2023-01-05 Required Reviews Completed, major revision<br>2023-01-28 重新提交修改稿, with edtior<br>2023-01-29 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21d92362370, createdName=Sweet123, createdTime=Mon Jan 30 12:06:58 CST 2023, time=2023-01-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187884, encodeId=fc93218e884ce, content=请问大家,第一次投稿JFF,with editor后直接decision in process是拒稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Sun Feb 18 08:03:27 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186348, encodeId=dbc72186348eb, content=审稿速度:2.0<br>偏重的研究方向:食品功能<br>经验分享:返修中,期待有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d538538122, createdName=ms6000002095545543, createdTime=Wed Feb 07 13:19:12 CST 2024, time=2024-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2150747, encodeId=3c822150e474b, content=想问一下 这个杂志 可选非OA吗?版面费太贵了<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Aug 01 10:32:16 CST 2023, time=2023-08-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=573893, encodeId=f4455e3893bf, content=请问后面接受了吗?<span class="quote">Cminor的忧郁 2019-04-29 00:00:00 发表:<br>四个月了还在under review</span>, beContent=Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5042220513, createdName=120fb885m31(暂无昵称), createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581042, encodeId=f3ba58104245, content=这个杂志的文章为什么在pubmed搜不到?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d2f1675433, createdName=Todbio, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056315, encodeId=1c49105631504, content=这个杂志的文章,为什么知网和pub med都搜不到呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/e31c71b7378048e29cf3e99f8858c0da/f8a0c38f56ec4460ac9c91ae10e0571a.jpg, createdBy=c39f5362798, createdName=ms7866968361536942, createdTime=Wed Sep 29 23:31:20 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856426, encodeId=f56a8564267a, content=已经oa了,收费1750刀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcef5414005, createdName=ms1092406316746404, createdTime=Fri Jan 03 10:27:16 CST 2020, time=2020-01-03, status=1, ipAttribution=)]
    2024-02-07 ms6000002095545543 来自河南省

    审稿速度:2.0
    偏重的研究方向:食品功能
    经验分享:返修中,期待有好消息

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2145064, encodeId=c0e72145064ca, content=为什么PubMed和WOS搜不到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Tue Jun 27 18:35:51 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2181071, encodeId=a29021810e106, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:中药;肠道菌群<br>经验分享:正在投稿中,期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13435547176, createdName=ms3000000331499189, createdTime=Fri Jan 12 22:29:17 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2112105, encodeId=1b9121121052b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:2022-11-07 submission<br>2022-12-21 Under Review<br>2023-01-05 Required Reviews Completed, major revision<br>2023-01-28 重新提交修改稿, with edtior<br>2023-01-29 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21d92362370, createdName=Sweet123, createdTime=Mon Jan 30 12:06:58 CST 2023, time=2023-01-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187884, encodeId=fc93218e884ce, content=请问大家,第一次投稿JFF,with editor后直接decision in process是拒稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Sun Feb 18 08:03:27 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186348, encodeId=dbc72186348eb, content=审稿速度:2.0<br>偏重的研究方向:食品功能<br>经验分享:返修中,期待有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d538538122, createdName=ms6000002095545543, createdTime=Wed Feb 07 13:19:12 CST 2024, time=2024-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2150747, encodeId=3c822150e474b, content=想问一下 这个杂志 可选非OA吗?版面费太贵了<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Aug 01 10:32:16 CST 2023, time=2023-08-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=573893, encodeId=f4455e3893bf, content=请问后面接受了吗?<span class="quote">Cminor的忧郁 2019-04-29 00:00:00 发表:<br>四个月了还在under review</span>, beContent=Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5042220513, createdName=120fb885m31(暂无昵称), createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581042, encodeId=f3ba58104245, content=这个杂志的文章为什么在pubmed搜不到?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d2f1675433, createdName=Todbio, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056315, encodeId=1c49105631504, content=这个杂志的文章,为什么知网和pub med都搜不到呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/e31c71b7378048e29cf3e99f8858c0da/f8a0c38f56ec4460ac9c91ae10e0571a.jpg, createdBy=c39f5362798, createdName=ms7866968361536942, createdTime=Wed Sep 29 23:31:20 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856426, encodeId=f56a8564267a, content=已经oa了,收费1750刀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcef5414005, createdName=ms1092406316746404, createdTime=Fri Jan 03 10:27:16 CST 2020, time=2020-01-03, status=1, ipAttribution=)]
    2023-08-01 ms8000001972745472 来自河南省

    想问一下 这个杂志 可选非OA吗?版面费太贵了

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2145064, encodeId=c0e72145064ca, content=为什么PubMed和WOS搜不到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Tue Jun 27 18:35:51 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2181071, encodeId=a29021810e106, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:中药;肠道菌群<br>经验分享:正在投稿中,期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13435547176, createdName=ms3000000331499189, createdTime=Fri Jan 12 22:29:17 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2112105, encodeId=1b9121121052b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:2022-11-07 submission<br>2022-12-21 Under Review<br>2023-01-05 Required Reviews Completed, major revision<br>2023-01-28 重新提交修改稿, with edtior<br>2023-01-29 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21d92362370, createdName=Sweet123, createdTime=Mon Jan 30 12:06:58 CST 2023, time=2023-01-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187884, encodeId=fc93218e884ce, content=请问大家,第一次投稿JFF,with editor后直接decision in process是拒稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Sun Feb 18 08:03:27 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186348, encodeId=dbc72186348eb, content=审稿速度:2.0<br>偏重的研究方向:食品功能<br>经验分享:返修中,期待有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d538538122, createdName=ms6000002095545543, createdTime=Wed Feb 07 13:19:12 CST 2024, time=2024-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2150747, encodeId=3c822150e474b, content=想问一下 这个杂志 可选非OA吗?版面费太贵了<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Aug 01 10:32:16 CST 2023, time=2023-08-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=573893, encodeId=f4455e3893bf, content=请问后面接受了吗?<span class="quote">Cminor的忧郁 2019-04-29 00:00:00 发表:<br>四个月了还在under review</span>, beContent=Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5042220513, createdName=120fb885m31(暂无昵称), createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581042, encodeId=f3ba58104245, content=这个杂志的文章为什么在pubmed搜不到?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d2f1675433, createdName=Todbio, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056315, encodeId=1c49105631504, content=这个杂志的文章,为什么知网和pub med都搜不到呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/e31c71b7378048e29cf3e99f8858c0da/f8a0c38f56ec4460ac9c91ae10e0571a.jpg, createdBy=c39f5362798, createdName=ms7866968361536942, createdTime=Wed Sep 29 23:31:20 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856426, encodeId=f56a8564267a, content=已经oa了,收费1750刀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcef5414005, createdName=ms1092406316746404, createdTime=Fri Jan 03 10:27:16 CST 2020, time=2020-01-03, status=1, ipAttribution=)]
    2019-07-22 120fb885m31(暂无昵称)

    请问后面接受了吗?Cminor的忧郁 2019-04-29 00:00:00 发表:
    四个月了还在under review

    Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2145064, encodeId=c0e72145064ca, content=为什么PubMed和WOS搜不到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Tue Jun 27 18:35:51 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2181071, encodeId=a29021810e106, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:中药;肠道菌群<br>经验分享:正在投稿中,期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13435547176, createdName=ms3000000331499189, createdTime=Fri Jan 12 22:29:17 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2112105, encodeId=1b9121121052b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:2022-11-07 submission<br>2022-12-21 Under Review<br>2023-01-05 Required Reviews Completed, major revision<br>2023-01-28 重新提交修改稿, with edtior<br>2023-01-29 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21d92362370, createdName=Sweet123, createdTime=Mon Jan 30 12:06:58 CST 2023, time=2023-01-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187884, encodeId=fc93218e884ce, content=请问大家,第一次投稿JFF,with editor后直接decision in process是拒稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Sun Feb 18 08:03:27 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186348, encodeId=dbc72186348eb, content=审稿速度:2.0<br>偏重的研究方向:食品功能<br>经验分享:返修中,期待有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d538538122, createdName=ms6000002095545543, createdTime=Wed Feb 07 13:19:12 CST 2024, time=2024-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2150747, encodeId=3c822150e474b, content=想问一下 这个杂志 可选非OA吗?版面费太贵了<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Aug 01 10:32:16 CST 2023, time=2023-08-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=573893, encodeId=f4455e3893bf, content=请问后面接受了吗?<span class="quote">Cminor的忧郁 2019-04-29 00:00:00 发表:<br>四个月了还在under review</span>, beContent=Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5042220513, createdName=120fb885m31(暂无昵称), createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581042, encodeId=f3ba58104245, content=这个杂志的文章为什么在pubmed搜不到?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d2f1675433, createdName=Todbio, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056315, encodeId=1c49105631504, content=这个杂志的文章,为什么知网和pub med都搜不到呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/e31c71b7378048e29cf3e99f8858c0da/f8a0c38f56ec4460ac9c91ae10e0571a.jpg, createdBy=c39f5362798, createdName=ms7866968361536942, createdTime=Wed Sep 29 23:31:20 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856426, encodeId=f56a8564267a, content=已经oa了,收费1750刀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcef5414005, createdName=ms1092406316746404, createdTime=Fri Jan 03 10:27:16 CST 2020, time=2020-01-03, status=1, ipAttribution=)]
    2019-12-06 Todbio

    这个杂志的文章为什么在pubmed搜不到?

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2145064, encodeId=c0e72145064ca, content=为什么PubMed和WOS搜不到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Tue Jun 27 18:35:51 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2181071, encodeId=a29021810e106, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:中药;肠道菌群<br>经验分享:正在投稿中,期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13435547176, createdName=ms3000000331499189, createdTime=Fri Jan 12 22:29:17 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2112105, encodeId=1b9121121052b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:2022-11-07 submission<br>2022-12-21 Under Review<br>2023-01-05 Required Reviews Completed, major revision<br>2023-01-28 重新提交修改稿, with edtior<br>2023-01-29 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21d92362370, createdName=Sweet123, createdTime=Mon Jan 30 12:06:58 CST 2023, time=2023-01-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187884, encodeId=fc93218e884ce, content=请问大家,第一次投稿JFF,with editor后直接decision in process是拒稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Sun Feb 18 08:03:27 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186348, encodeId=dbc72186348eb, content=审稿速度:2.0<br>偏重的研究方向:食品功能<br>经验分享:返修中,期待有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d538538122, createdName=ms6000002095545543, createdTime=Wed Feb 07 13:19:12 CST 2024, time=2024-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2150747, encodeId=3c822150e474b, content=想问一下 这个杂志 可选非OA吗?版面费太贵了<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Aug 01 10:32:16 CST 2023, time=2023-08-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=573893, encodeId=f4455e3893bf, content=请问后面接受了吗?<span class="quote">Cminor的忧郁 2019-04-29 00:00:00 发表:<br>四个月了还在under review</span>, beContent=Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5042220513, createdName=120fb885m31(暂无昵称), createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581042, encodeId=f3ba58104245, content=这个杂志的文章为什么在pubmed搜不到?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d2f1675433, createdName=Todbio, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056315, encodeId=1c49105631504, content=这个杂志的文章,为什么知网和pub med都搜不到呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/e31c71b7378048e29cf3e99f8858c0da/f8a0c38f56ec4460ac9c91ae10e0571a.jpg, createdBy=c39f5362798, createdName=ms7866968361536942, createdTime=Wed Sep 29 23:31:20 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856426, encodeId=f56a8564267a, content=已经oa了,收费1750刀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcef5414005, createdName=ms1092406316746404, createdTime=Fri Jan 03 10:27:16 CST 2020, time=2020-01-03, status=1, ipAttribution=)]
    2021-09-29 ms7866968361536942

    这个杂志的文章,为什么知网和pub med都搜不到呢?

    3

    展开3条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2145064, encodeId=c0e72145064ca, content=为什么PubMed和WOS搜不到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Tue Jun 27 18:35:51 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2181071, encodeId=a29021810e106, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:中药;肠道菌群<br>经验分享:正在投稿中,期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13435547176, createdName=ms3000000331499189, createdTime=Fri Jan 12 22:29:17 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2112105, encodeId=1b9121121052b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:2022-11-07 submission<br>2022-12-21 Under Review<br>2023-01-05 Required Reviews Completed, major revision<br>2023-01-28 重新提交修改稿, with edtior<br>2023-01-29 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21d92362370, createdName=Sweet123, createdTime=Mon Jan 30 12:06:58 CST 2023, time=2023-01-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187884, encodeId=fc93218e884ce, content=请问大家,第一次投稿JFF,with editor后直接decision in process是拒稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Sun Feb 18 08:03:27 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186348, encodeId=dbc72186348eb, content=审稿速度:2.0<br>偏重的研究方向:食品功能<br>经验分享:返修中,期待有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d538538122, createdName=ms6000002095545543, createdTime=Wed Feb 07 13:19:12 CST 2024, time=2024-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2150747, encodeId=3c822150e474b, content=想问一下 这个杂志 可选非OA吗?版面费太贵了<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Aug 01 10:32:16 CST 2023, time=2023-08-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=573893, encodeId=f4455e3893bf, content=请问后面接受了吗?<span class="quote">Cminor的忧郁 2019-04-29 00:00:00 发表:<br>四个月了还在under review</span>, beContent=Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5042220513, createdName=120fb885m31(暂无昵称), createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581042, encodeId=f3ba58104245, content=这个杂志的文章为什么在pubmed搜不到?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d2f1675433, createdName=Todbio, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056315, encodeId=1c49105631504, content=这个杂志的文章,为什么知网和pub med都搜不到呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/e31c71b7378048e29cf3e99f8858c0da/f8a0c38f56ec4460ac9c91ae10e0571a.jpg, createdBy=c39f5362798, createdName=ms7866968361536942, createdTime=Wed Sep 29 23:31:20 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856426, encodeId=f56a8564267a, content=已经oa了,收费1750刀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcef5414005, createdName=ms1092406316746404, createdTime=Fri Jan 03 10:27:16 CST 2020, time=2020-01-03, status=1, ipAttribution=)]
    2020-01-03 ms1092406316746404

    已经oa了,收费1750刀

    3

    展开3条回复
共178条页码: 1/18页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分